Patents by Inventor Frederic Bard

Frederic Bard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240117023
    Abstract: Disclosed herein are methods and treatments for cartilage degradation, wherein the method comprises administration of a therapeutic agent which inhibits the Ga1N Ac-T activation (GALA) pathway.
    Type: Application
    Filed: July 21, 2023
    Publication date: April 11, 2024
    Applicants: Agency for Science, Technology and Research, Tan Tock Seng Hospital Pte Ltd
    Inventors: Frederic Bard, Le Son Tran, Khai Pang Leong, Joanne Zhi Hui Chia
  • Publication number: 20240052023
    Abstract: We describe a Cnx/ERp57 inhibitor for use in the treatment or prevention of cancer.
    Type: Application
    Filed: August 14, 2023
    Publication date: February 15, 2024
    Applicant: Agency for Science, Technology and Research
    Inventors: Frederic Bard, Anh Tuan Nguyen, Ros Manon
  • Publication number: 20220363738
    Abstract: METHOD Herein is described a Cnx/ERp57 inhibitor for use in the treatment or prevention of cancer.
    Type: Application
    Filed: January 6, 2022
    Publication date: November 17, 2022
    Applicant: Agency for Science, Technology and Research
    Inventors: Frederic Bard, Anh Tuan Nguyen, Ros Manon
  • Publication number: 20220146497
    Abstract: A method of identifying fibrotic agents capable of modulating a fibrotic process or condition is provided, along with compositions containing such compounds. The method involves contacting a plurality of fibroblasts with a test compound and determining whether the compound modulates expression of a gene that inhibits collagen synthesis. Compounds capable of regulating the expression of a gene that inhibits collagen synthesis may be useful for modulating a fibrotic process or treating a fibrotic condition.
    Type: Application
    Filed: January 24, 2022
    Publication date: May 12, 2022
    Inventors: Robert Joseph ISFORT, Frederic BARD, Hui Hui WONG, Sze Hwee SEET
  • Publication number: 20200354411
    Abstract: Disclosed herein are chimeric fusion proteins comprising a c-Myc inhibitor fused to genetically modified Pseudomonas Aeroginosa Exotoxin A (‘tPE’), said fusion proteins being capable of penetrating a nucleus of a cell and inhibiting c-Myc activity within the nucleus. Also disclosed herein are pharmaceutical compositions comprising chimeric fusion proteins, methods of delivering, methods of preparing, methods of treating and uses of chimeric fusion proteins.
    Type: Application
    Filed: November 29, 2018
    Publication date: November 12, 2020
    Inventors: Frederic Bard, Alexandre Chaumet, Trinda Anne Ting
  • Publication number: 20200264186
    Abstract: Disclosed herein are methods of detecting the presence or absence of cancer. Also disclosed herein are methods of characterising a sample from a subject thought to be suffering cancer, as well as methods of determining the malignancy, grade, or staging of a cancer. Also disclosed herein are kits utilising the methods disclosed herein.
    Type: Application
    Filed: October 4, 2018
    Publication date: August 20, 2020
    Inventors: Frederic Bard, Zhi Hui Joanne Chia
  • Publication number: 20020004918
    Abstract: A method is for the preparation and execution of a self-test procedure to validate the behavior of a processor model to be tested. The processor model may be a processor or an associated simulator. The method provides self-test procedures that are immediately executable by all the models of a processor and that give OK/ERROR type results that are easy to interpret.
    Type: Application
    Filed: May 30, 2001
    Publication date: January 10, 2002
    Applicant: STMicroelectronics S.A.
    Inventors: Frederic Mathieu, Frederic Bard